Thromboxane Production in Human Lung During Cardiopulmonary Bypass: Beneficial Effect of Aspirin?
- 31 January 1998
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 65 (1), 101-106
- https://doi.org/10.1016/s0003-4975(97)01040-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cardiac-derived thromboxane A2The Journal of Thoracic and Cardiovascular Surgery, 1993
- Thromboxane A2 mediates increased pulmonary microvascular permeability following limb ischemia.Circulation Research, 1989
- Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in catsAmerican Heart Journal, 1989
- Thromboxane synthetase inhibitors reduce infarct size by a platelet-dependent, aspirin-sensitive mechanism.Circulation Research, 1988
- Endothelial-secreted arachidonic acid metabolites modulate polymorphonuclear leukocyte chemotaxis and diapedesis in vitroBlood, 1988
- Synthesis and structure of the platelet aggregation factor thromboxane A2Nature, 1985
- Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.Circulation, 1980
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971